StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck research and Development (R&D) ($M) ($M)

Postgres DB financial_values

QuarterlyAnnual
Latest, FY2025
15,789
Period ended Dec 31, 2025
Change on a year earlier
-12.0%
17,938 in FY2024
History
19 years
Since FY2007
Sources
13
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedResearch and Development (R&D) ($M) ($M)Year on yearSource
FY2025Dec 31, 202515,789-12.0%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 202417,938-41.2%Form 10-K (filed 2025-02-25) ↗
FY2023Dec 31, 202330,531+125.4%Form 10-K (filed 2024-02-26) ↗
FY2022Dec 31, 202213,548+10.6%Form 10-K (filed 2023-02-24) ↗
FY2021Dec 31, 202112,245-8.6%Form 10-K (filed 2022-02-25) ↗
FY2020Dec 31, 202013,397+37.8%Form 10-K (filed 2022-02-25) ↗
FY2019Dec 31, 20199,724-0.3%Form 10-K (filed 2022-02-25) ↗
FY2018Dec 31, 20189,752-5.7%Form 10-K (filed 2019-02-27) ↗
FY2017Dec 31, 201710,339+0.8%Form 10-K (filed 2019-02-27) ↗
FY2016Dec 31, 201610,261+53.1%Form 10-K (filed 2019-02-27) ↗
FY2015Dec 31, 20156,704-6.6%Form 10-K (filed 2016-02-26) ↗
FY2014Dec 31, 20147,180-4.3%Form 10-K (filed 2015-02-27) ↗
FY2013Dec 31, 20137,503-8.1%Form 10-K (filed 2014-02-27) ↗
FY2012Dec 31, 20128,168-3.5%Form 10-K (filed 2013-02-28) ↗
FY2011Dec 31, 20118,467-23.8%Form 10-K (filed 2012-02-28) ↗
FY2010Dec 31, 201011,111+90.1%Form 10-K (filed 2012-02-28) ↗

Cite this data

StockData. (2026). Merck Research and Development (R&D) ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_inc_rd

See every metric in the Merck KPI table. Data updated Oct 26, 2026.